(A) Construction of pre-ABHD2 and sh-ABHD2 confirmed by RT-qPCR. (B) Construction of pre-NUDT21 and sh-NUDT21 confirmed by RT-qPCR. (C) Statistical analysis of invasion in human cervical cancer cells (CaSki and C33A) treated with pre-ABHD2 and sh-ABHD2. (D) Transwell pictures of cell invasion in CaSki and C33A cells. (E) Statistical analysis of migration in human cervical cancer cells (CaSki and C33A) treated with pre-ABHD2 and sh-ABHD2. (F) Transwell assay was used to detect cell migration in CaSki and C33A cells. All data were obtained in triplicate; *, **, and *** indicate P<0.05, P<0.01, and P<0.001, respectively.